title: Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
authors.forename: D
authors.initials: D
authors.lastname: Métivier
authors.forename: F-X
authors.initials: FX
authors.lastname: Arnaud
authors.forename: F
authors.initials: F
authors.lastname: Dutasta
authors.forename: B
authors.initials: B
authors.lastname: Nguema
authors.forename: C
authors.initials: C
authors.lastname: Teriitehau
authors.forename: O
authors.initials: O
authors.lastname: Berets
authors.forename: J
authors.initials: J
authors.lastname: Baccialone
authors.forename: J
authors.initials: J
authors.lastname: Potet
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications*; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy; D000069442:Natalizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab